Publications

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

AuthID
P-00F-XQR

Author(s)

Dodel, R

Rominger, A

Bartenstein, P

Barkhof, F

Blennow, K

Forster, S

Winter, Y

Bach, JP

Popp, J

Alferink, J

Wiltfang, J

[+3]·

Jacoby, M

Richter, R

Stevens, J

Melamed, I

Goldstein, J

Haag, S

Wietek, S

Farlow, M

Jessen, F

View all authors

Document Type

Article

Year published

2013

Published

in The Lancet Neurology, ISSN: 1474-4422

Volume: 12, Issue: 3, Pages: 233-243

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s1474-4422(13)70014-0

Pubmed: 23375965

Scopus: 2-s2.0-84876307732

Source Identifiers

ISSN: 1474-4422

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Show entries

Search:

Name Order	Name	Name Order	Name	Name Order	Name
1	Dodel, R;	2	Rominger, A;	3	Bartenstein, P;
4	Barkhof, F;	5	Blennow, K;	6	Forster, S;
7	Winter, Y;	8	Bach, JP;	9	Popp, J;
10	Alferink, J;	11	Wiltfang, J;	12	Buerger, K;
13	Otto, M;	14	Antuono, P;	15	Jacoby, M;
16	Richter, R;	17	Stevens, J;	18	Melamed, I;
19	Goldstein, J;	20	Haag, S;	21	Wietek, S;
22	Farlow, M;	23	Jessen, F;

Showing 1 to 8 of 8 entries

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

Useful Links

Get Help